High concentration Anti-c5 formulations
MYPI2025002172A0Undetermined Publication Date: 2021-02-16REGENERON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025002172
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-08-14
- Filing Date
- 2020-08-14
- Publication Date
- 2021-02-16
Abstract
The present disclosure includes high concentration, low viscosity pharmaceutical formulations that include an anti-C5 antibody or antigen-binding fragment thereof and arginine. Such formulations may be provided in association with an RNAi molecule such as cemdisiran. Methods of treating C5-associated diseases such as PNH and aHUS are also provided.
Need to check novelty before this filing date? Find Prior Art
